When proteins get stuck at solid: Unlocking the secrets to brain diseases
Nanoscale view of proteins opens window to treat neurodegenerative illness
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Alzheimer’s disease
Eisai submits MAA for lecanemab in Great Britain to treat early Alzheimer’s disease
Lecanemab has been designated by the MHRA for the Innovative Licensing and Access Pathway
USFDA accepts Eisai’s sBLA and grants priority review for approval of LEQEMBITM…
USFDA accepts Eisai's sBLA and grants priority review for approval of LEQEMBITM Alzheimer's treatment
Biogen gets US FDA accelerated approval for Aduhelm to treat Alzheimer’s
It is the first new treatment approved for Alzheimer's since 2003 and is the first therapy that targets the fundamental…
Re-purposed drugs could reverse blood vessel damage in diabetes
In a breakthrough, scientists have discovered a key mechanism that triggers changes in the blood vessels, which can eventually…
US FDA approves first drug to image Tau Pathology in Alzheimer’s Disease related cases
Tauvid is a radioactive diagnostic agent for adult patients with cognitive impairment who are being evaluated for Alzheimer’s…
IIT Guwahati discovers new ways to prevent memory loss due to Alzheimer
They studied the neurochemical principles of Alzheimer’s, and explored new ways to prevent accumulation of neurotoxic molecules in…
Novartis in global partnership with Amgen
To develop and commercialise pioneering neuroscience treatments Novartis has entered into a global collaboration with Amgen to…
Suven initiates MAD studies in phase 1 clinical trial for investigational compound SUVN-G3031
SUVN-G3031 is a potent, selective, brain penetrant and orally active Histamine H3 inverse agonist being developed for the…